Molina Healthcare (NYSE:MOH) Releases FY 2029 Earnings Guidance

Molina Healthcare (NYSE:MOH) updated its FY 2029 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 25.000-25.000 for the period, compared to the consensus estimate of 28.930. The company issued revenue guidance of -.

Molina Healthcare Stock Down 4.7%

Shares of MOH traded down $9.04 during mid-day trading on Friday, reaching $182.81. The company’s stock had a trading volume of 893,054 shares, compared to its average volume of 1,721,678. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. Molina Healthcare has a 12-month low of $121.06 and a 12-month high of $333.00. The stock has a market cap of $9.52 billion, a PE ratio of 54.09 and a beta of 0.85. The company’s 50 day moving average is $152.32 and its 200 day moving average is $158.52.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.78. The firm had revenue of $10.80 billion during the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The firm’s revenue was down 3.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Equities analysts anticipate that Molina Healthcare will post 5.21 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on MOH shares. Wells Fargo & Company upped their target price on shares of Molina Healthcare from $141.00 to $159.00 and gave the company an “equal weight” rating in a report on Monday, April 27th. Weiss Ratings reissued a “sell (d+)” rating on shares of Molina Healthcare in a research report on Tuesday, April 21st. Truist Financial upped their price objective on shares of Molina Healthcare from $145.00 to $180.00 and gave the company a “hold” rating in a research note on Monday, April 27th. Barclays raised their price objective on Molina Healthcare from $133.00 to $161.00 and gave the stock an “underweight” rating in a report on Friday, April 24th. Finally, Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price for the company in a report on Wednesday, April 29th. Three analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Molina Healthcare currently has a consensus rating of “Hold” and an average price target of $169.60.

Institutional Investors Weigh In On Molina Healthcare

Several hedge funds have recently modified their holdings of MOH. T. Rowe Price Investment Management Inc. boosted its stake in shares of Molina Healthcare by 10.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company’s stock valued at $376,831,000 after buying an additional 201,772 shares in the last quarter. Invesco Ltd. raised its position in Molina Healthcare by 24.2% in the fourth quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock worth $293,453,000 after acquiring an additional 329,679 shares in the last quarter. Corient Private Wealth LLC lifted its holdings in Molina Healthcare by 38.9% in the fourth quarter. Corient Private Wealth LLC now owns 10,220 shares of the company’s stock valued at $1,654,000 after acquiring an additional 2,864 shares during the period. Alberta Investment Management Corp acquired a new stake in Molina Healthcare in the fourth quarter valued at $1,562,000. Finally, Beacon Pointe Advisors LLC boosted its position in shares of Molina Healthcare by 9.9% during the 4th quarter. Beacon Pointe Advisors LLC now owns 1,416 shares of the company’s stock worth $246,000 after purchasing an additional 128 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.